σ Receptor Activation Does Not Mediate Fentanyl-lnduced Attenuation of Muscarinic Coronary Contraction

Anesthesia and Analgesia

Volumn 82, Issue 5, 1996, Pages 982-987

  Tsuchida, Hideaki ^a   Schubert, Armin ^a   Estafanous, Fawzy G ^a   Brum, Jose M ^a   Murray, Paul A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; FENTANYL; MUSCARINIC RECEPTOR;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INNERVATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; SWINE;

ACETYLCHOLINE; ANESTHETICS, INTRAVENOUS; ANIMALS; CORONARY VESSELS; CYCLAZOCINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; FENTANYL; GUANIDINES; HALOPERIDOL; MUSCARINE; MUSCARINIC AGONISTS; NARCOTIC ANTAGONISTS; NARCOTICS; PENTAZOCINE; PHENCYCLIDINE; PIPERIDINES; POTASSIUM CHANNEL BLOCKERS; RECEPTORS, DOPAMINE; RECEPTORS, SIGMA; SIGNAL TRANSDUCTION; SWINE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0029874320     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199605000-00016     Document Type: Article

References (26)

1. Vita JA, Treasure CB, Yeung AC, et al. Patients with evidence of., coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation 1992;85:1390-7.
2. Meredith IT, Anderson TJ, Uehata A, et al. Role of endothelium in ischemic coronary syndromes [review]. Am J Cardiol 1993;72:27C-32C
3. Yamanoue T, Brum JM, Estafanous FG, et al. Effects of opioids on vasoresponsiveness of porcine coronary artery. Anesth Analg 1992;74:889-96.
4. 3-muscarinic antagonism. Anesth Analg 1993;76:382-90.
5. Toda N, Hatano Y. Contractile responses of canine tracheal muscle during exposure to fentanyl and morphine. Anesthesiology 1980;53:93-100.
6. Pleuvry BF. Opioid receptors and their relevance to anaesthesia. Br J Anaesth 1993;71:119-26.
7. Ocana M, Del Pozo E, Barrios M, et al. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol 1990;186:377-8.
8. Wild KD, Vanderah T, Mosberg HI, et al. Opioid δ receptor subtypes are associated with different potassium channels. Eur J Pharmacol 1991;193:135-6.
9. Suzuki T, Funada M, Narita M, et al. Pertussis toxin abolishes μ-and δ-opioid agonist-induced place preference. Eur J Pharmacol 1991;205:85-8.
10. Childers SR. Opioid receptor-coupled second messenger systems. Life Sci 1991;48:1991-2003.
11. Gross RA, Macdonald RL. Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture. Proc Natl Acad Sci USA 1987;84:5469-73.
12. Jaffe JH, Martin WR. Opioid analgesics and antagonists. In: Goodman AG, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990:485-521.
13. Largent BL, Wikstrom H, Gundlach AL, et al. Structure determinants of σ receptor affinity. Mol Pharmacol 1987;32:772-84.
14. Walker JM, Bowen WD, Walker FO, et al. Sigma receptors: biology and function. Pharmacol Rev 1990;42:355-402.
15. Su TP. Delineating biochemical and functional properties of sigma receptors: emerging concepts. Crit Rev Neurobiol 1993;7:187-203.
16. Bowen WD, Kirschner BN, Newman AH, et al. σ receptors negatively modulate agonist-stimulated phosphoinositide metabolism in rat brain. Eur J Pharmacol 1988;149:399-400.
17. Brog JS, Beinfeld MC. Inhibition of carbachol-induced inositol phosphate accumulation by phencyclidine, phencyclidine-like ligands and sigma agonists involves blockade of the muscarinic cholinergic receptor: a novel dioxadrol-preferring interaction. J Pharmacol Exp Ther 1990;254:952-6.
18. Bowen WD, Tolentino PJ, Kirschner BN, et al. σ receptors and signal transduction: negative modulation of signaling through phosphoinositide-linked receptor systems. In: DeSouza EB, Clouet DH, eds. Sigma, PCP, and NMDA receptor systems. NIDA Monograph Series. Washington, DC: U.S. Government Printing Office, 1990:69-93.
19. Vargas HM, Pechnick RN. Binding affinity and antimuscarinic activity of σ and phencyclidine receptor ligands. Eur J Pharmacol 1991;195:151-6.
20. Bluth LS, Rick KC, Jacobson AE, et al. Acylation of σ receptor by metaphit, an isothiocyanate derivative of phencyclidine. Eur J Pharmacol 1989;161:273-7.
21. Flavahan NA, Shimokawa H, Vanhoutte PM. Pertussis toxin inhibits endothelium-dependent relaxation to certain agonists in porcine coronary arteries. J Physiol (Lond) 1989;408:549-60.
22. 1 muscarinic antagonists interact with σ recognition sites. Life Sci 1991;49:1229-35.
23. Paul LA, Basile AS, Rojas E, et al. Sigma receptors modulate nicotinic receptor function in adrenal chromaffin cells. FASEB J 1993;7:1171-8.
24. Massamiri T, Duckles SP. Sigma receptor ligand inhibit rat tail artery contractile responses by multiple mechanisms. J Pharmacol Exp Ther 1991;259:22-9.
25. Wu XZ, Bell JA, Spivack CE, et al. Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor. J Pharmacol Exp Ther 1991;257:351-9.
26. van Charldorp KJ, van Zwieten PA. Comparison of the muscarinic receptors in the coronary artery, cerebral artery and atrium of the pig. Naunyn-Schmiedeberg's Arch Pharmacol 1989;339:403-8.